{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:09:16Z","timestamp":1781816956489,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.surg.2020.04.054","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T06:59:56Z","timestamp":1593932396000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-2718","authenticated-orcid":false,"given":"Jae Hyun","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-8443","authenticated-orcid":false,"given":"Jin Wook","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2020.04.054_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.surg.2020.04.054_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4143\/crt.2019.139","article-title":"Prediction of cancer incidence and mortality in Korea, 2019","volume":"51","author":"Jung","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.surg.2020.04.054_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2020.04.054_bib4","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1210\/en.2019-00315","article-title":"Impact of BRAF V600E and TERT promoter mutations on response to therapy in papillary thyroid cancer","volume":"160","author":"Trybek","year":"2019","journal-title":"Endocrinol"},{"key":"10.1016\/j.surg.2020.04.054_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2020.04.054_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/ERC-13-0291","article-title":"Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?","volume":"21","author":"Lang","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2020.04.054_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/thy.2018.0695","article-title":"TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas","volume":"29","author":"Tanaka","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2020.04.054_bib8","first-page":"4214","article-title":"Telomerase activity in human thyroid carcinomas originating from the follicular cells","volume":"82","author":"Brousset","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2020.04.054_bib9","first-page":"1483","article-title":"Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms","volume":"5","author":"Saji","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2020.04.054_bib10","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1038\/srep36990","article-title":"TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer: a meta-analysis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.surg.2020.04.054_bib11","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2020.04.054_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159235","article-title":"Significance of the BRAF mRNA expression level in papillary thyroid carcinoma: an analysis of The Cancer Genome Atlas Data","volume":"11","author":"Chai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2020.04.054_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.surg.2020.04.054_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1308\/rcsann.2017.0072","article-title":"Comparison of prognostic scoring\u00a0systems in follicular thyroid cancer","volume":"99","author":"Teo","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.surg.2020.04.054_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.surg.2020.04.054_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20122887","article-title":"Telomerase and telomeres biology in thyroid cancer","volume":"20","author":"Donati","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.surg.2020.04.054_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1101\/gad.2017311","article-title":"Making sense of cancer genomic data","volume":"25","author":"Chin","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.surg.2020.04.054_bib18","article-title":"TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors","volume":"7","author":"Matsuse","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.surg.2020.04.054_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2020.04.054_bib20","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.surg.2020.04.054_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/genes7070038","article-title":"Cancer-specific telomerase reverse transcriptase (TERT)\u00a0Promoter mutations: biological and clinical implications","volume":"7","author":"Liu","year":"2016","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.surg.2020.04.054_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/8.1.137","article-title":"The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter","volume":"8","author":"Cong","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.surg.2020.04.054_bib23","first-page":"551","article-title":"Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells","volume":"59","author":"Takakura","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2020.04.054_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.surg.2020.04.054_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2011.10.001","article-title":"Role of telomeres and telomerase in cancer","volume":"21","author":"Shay","year":"2011","journal-title":"Semin Cancer Biol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602030266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602030266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:54:39Z","timestamp":1758538479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003960602030266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S003960602030266X"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2020.04.054","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2020.04.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}